Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y393-p
BCR-ABL1 Y232-p , Y253-p , Y257-p
PAK2 S618-p , S619-p
TTK T735-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Abl Y393-p
ATM S446-p
CLK1 T735-p
CLK4 T735-p
Cot T735-p
Fyn Y70-p , Y115-p , Y128-p , Y139-p , Y172-p , Y185-p , Y215-p , Y226-p , Y393-p
Hck Y70-p , Y115-p , Y128-p , Y139-p , Y172-p , Y185-p , Y215-p , Y226-p , Y393-p
LYN Y70-p , Y115-p , Y128-p , Y139-p , Y172-p , Y185-p , Y215-p , Y226-p , Y393-p
MST1 T735-p
MST2 T735-p
PAK2 S618-p , S619-p
TTK T735-p
Regulatory protein:
Abi-1 Y226-p
Abl Y115-p , Y253-p , Y257-p , Y393-p , Y413-p
CLK1 T735-p
CLK4 T735-p
FGFR1 Y393-p
MST1 T735-p
MST2 T735-p
NDRG1 Y226-p
TTK T735-p
Treatment:
adriamycin T735-p
AP23464 Y257-p
bosentan Y226-p
dactolisib Y226-p
dasatinib Y226-p , Y393-p , S569-p
EGF Y226-p
endothelin Y226-p
ephrin_B1 Y232-p , Y393-p
ephrin_B2 Y393-p
H2O2 T735-p
hypertonic_buffer Y226-p , Y393-p
hypoxia Y185-p
imatinib Y115-p , Y226-p , Y393-p , T735-p
ionizing_radiation S446-p
ischemia S718-p
LPA S569-p
LRRK2-IN-1 S569-p
MG132 S859-p
MG132_withdrawal T610-p , T613-p , S683-p , T844-p , T852-p , T854-p , S936-p
nilotinib Y226-p
nocodazole Y393-p , T613-p , S805-p , T814-p
RAD001 T735-p
selumetinib T852-p
siRNA T735-p
Su11274 Y393-p
thymidine Y393-p , T613-p , S805-p , T814-p
U0126 Y393-p
vemurafenib T852-p